Oncogenic Mechanisms and Therapeutic Targeting of Metabolism in Leukemia and Lymphoma.


Journal

Cold Spring Harbor perspectives in medicine
ISSN: 2157-1422
Titre abrégé: Cold Spring Harb Perspect Med
Pays: United States
ID NLM: 101571139

Informations de publication

Date de publication:
01 07 2021
Historique:
pubmed: 21 8 2020
medline: 16 12 2021
entrez: 21 8 2020
Statut: epublish

Résumé

Leukemias and lymphomas acquire the capacity for unrestrained cell growth and proliferation in conjunction with loss of responsiveness to molecular programs that promote terminal differentiation. Malignant cells generate the building blocks required for rapid cell division through both increased acquisition of nutrients from the environment and reprogrammed intermediary metabolism to shunt these molecules into producing the protein, lipids, and nucleic acids that comprise cell biomass. These accelerated metabolic processes require energy in the form of ATP and reducing equivalents in the form of NADPH, which power biosynthetic reactions and buffer oxidative stress encountered by the metabolically active cancer cell. Cancer-associated metabolic alterations can also promote accumulation or depletion of specific metabolites that directly regulate cell fate and function, thereby coupling metabolic reprogramming to dedifferentiation and stemness. This review will focus on the mechanisms by which leukemia and lymphoma cells rewire cellular metabolism to support: (1) bioenergetics, (2) biomass accumulation, (3) redox balance, and (4) differentiation blockade. We will further highlight examples of how specific pathways of leukemia and lymphoma metabolism confer therapeutic vulnerabilities that can be targeted to inhibit growth or promote differentiation.

Identifiants

pubmed: 32816875
pii: cshperspect.a035477
doi: 10.1101/cshperspect.a035477
pmc: PMC8247556
pii:
doi:

Substances chimiques

Carcinogens 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NCI NIH HHS
ID : K08 CA201483
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCI NIH HHS
ID : R37 CA251543
Pays : United States

Informations de copyright

Copyright © 2021 Cold Spring Harbor Laboratory Press; all rights reserved.

Références

Clin Cancer Res. 2019 Jul 1;25(13):4079-4090
pubmed: 30940653
Cell Stem Cell. 2013 Mar 7;12(3):329-41
pubmed: 23333149
Nature. 2012 Jul 12;487(7406):244-8
pubmed: 22722845
Cancer Cell. 2011 Nov 15;20(5):674-88
pubmed: 22094260
Blood. 2017 May 11;129(19):2657-2666
pubmed: 28283480
Cell Metab. 2019 May 7;29(5):1217-1231.e7
pubmed: 30773463
Nature. 2018 Aug;560(7719):499-503
pubmed: 30051890
Cell Metab. 2013 Jan 8;17(1):113-24
pubmed: 23274086
EMBO J. 2010 Jun 16;29(12):2082-96
pubmed: 20473272
Cancer Cell. 2012 Nov 13;22(5):631-44
pubmed: 23153536
Nat Med. 2015 Feb;21(2):178-84
pubmed: 25599133
Nat Genet. 2016 Feb;48(2):183-8
pubmed: 26691987
Sci Transl Med. 2019 Oct 30;11(516):
pubmed: 31666400
Nat Genet. 2013 Mar;45(3):290-4
pubmed: 23377183
Nat Med. 2017 Jan;23(1):79-90
pubmed: 27941793
Nature. 2013 Jan 31;493(7434):689-93
pubmed: 23334421
Nature. 2019 Mar;567(7746):118-122
pubmed: 30760928
Cell Rep. 2018 Apr 10;23(2):349-360
pubmed: 29641996
Nat Rev Genet. 2016 May;17(5):284-99
pubmed: 26972587
Trends Cell Biol. 2018 Sep;28(9):698-708
pubmed: 29724526
Cell. 2014 Sep 11;158(6):1309-1323
pubmed: 25215489
Haematologica. 2020 Jan 23;105(11):2659-2663
pubmed: 33131256
Proc Natl Acad Sci U S A. 2016 Dec 27;113(52):15084-15089
pubmed: 27956631
Genes Dev. 2013 Apr 15;27(8):836-52
pubmed: 23630074
Mol Cancer Ther. 2019 Jan;18(1):3-16
pubmed: 30352802
Sci Immunol. 2017 Nov 17;2(17):
pubmed: 29150439
Cell Metab. 2019 Sep 3;30(3):539-555.e11
pubmed: 31257153
Nature. 2008 May 1;453(7191):110-4
pubmed: 18408710
Cancer. 2004 Mar 15;100(6):1179-85
pubmed: 15022284
Nat Metab. 2019 Feb;1(2):177-188
pubmed: 31245788
Nat Commun. 2018 Mar 16;9(1):1107
pubmed: 29549331
J Biol Chem. 2000 Jul 21;275(29):21797-800
pubmed: 10823814
Cancer Metab. 2014 Mar 10;2(1):4
pubmed: 24612826
Cell Stem Cell. 2016 Jul 7;19(1):23-37
pubmed: 27374788
Nature. 2017 May 25;545(7655):500-504
pubmed: 28514443
J Biol Chem. 2009 Nov 20;284(47):32742-9
pubmed: 19783659
Nature. 2017 Sep 28;549(7673):476-481
pubmed: 28825709
Nat Med. 2018 Dec;24(12):1859-1866
pubmed: 30420752
Br J Haematol. 1998 Jul;102(2):522-7
pubmed: 9695968
Clin Cancer Res. 2016 Nov 1;22(21):5383-5393
pubmed: 27267853
Exp Hematol. 2018 Feb;58:52-58
pubmed: 28947392
Nat Metab. 2019 Mar;1(3):390-403
pubmed: 31535081
Nature. 2017 Nov 16;551(7680):384-388
pubmed: 29144447
Oncotarget. 2017 Jun 28;8(40):67639-67650
pubmed: 28978059
Blood Cancer J. 2017 Jul 7;7(7):e0
pubmed: 28686226
Blood. 2015 Oct 8;126(15):1741-52
pubmed: 26268241
Nat Med. 2016 Apr;22(4):379-87
pubmed: 26974310
Blood. 2009 Feb 26;113(9):2014-21
pubmed: 18978206
Blood. 2013 Aug 1;122(5):749-58
pubmed: 23733335
Nat Metab. 2019 Sep;1(9):861-867
pubmed: 31598584
Cell. 2017 Feb 9;168(4):657-669
pubmed: 28187287
Oncotarget. 2017 Dec 19;9(3):4020-4033
pubmed: 29423101
Nature. 2020 Jun;582(7813):586-591
pubmed: 32494005
Clin Cancer Res. 2015 Apr 15;21(8):1828-34
pubmed: 25878364
Proc Natl Acad Sci U S A. 2012 Jul 17;109(29):11818-23
pubmed: 22752304
Cancer Discov. 2015 Oct;5(10):1024-39
pubmed: 26382145
Cancer Discov. 2017 Jul;7(7):716-735
pubmed: 28416471
Leukemia. 1994 Nov;8(11):2023-9
pubmed: 7967748
Sci Rep. 2017 Sep 12;7(1):11253
pubmed: 28900115
Leukemia. 2005 Dec;19(12):2153-8
pubmed: 16193082
Leukemia. 2019 Oct;33(10):2403-2415
pubmed: 30940908
Nature. 2014 Sep 25;513(7519):559-63
pubmed: 25043024
Cancer Cell. 2010 Mar 16;17(3):225-34
pubmed: 20171147
Cancer Cell. 2015 Jun 8;27(6):864-76
pubmed: 26058080
Cell Metab. 2013 Aug 6;18(2):153-61
pubmed: 23791484
Cell. 2018 Apr 5;173(2):470-484.e18
pubmed: 29551267
Cancer Cell. 2019 Jul 8;36(1):84-99.e8
pubmed: 31287994
N Engl J Med. 1986 Sep 11;315(11):657-63
pubmed: 2943992
Nat Rev Drug Discov. 2009 Jul;8(7):579-91
pubmed: 19478820
Ann Oncol. 2009 Mar;20(3):508-12
pubmed: 19139176
J Biol Chem. 2010 Nov 19;285(47):36267-74
pubmed: 20813845
BMC Cancer. 2018 Apr 2;18(1):361
pubmed: 29609590
Br J Haematol. 2019 Aug;186(3):420-430
pubmed: 31044436
Nat Med. 2017 Jan;23(1):120-127
pubmed: 27869804
Blood. 2005 Mar 1;105(5):1851-61
pubmed: 15550490
Cell. 2015 Jul 30;162(3):540-51
pubmed: 26232224
Blood. 2018 Apr 12;131(15):1639-1653
pubmed: 29463564
Cell Death Differ. 2017 Feb;24(2):251-262
pubmed: 27768122
Nat Commun. 2015 Jul 16;6:7768
pubmed: 26178471
Cancer Res. 1996 Feb 15;56(4):745-51
pubmed: 8631008
Cell. 2016 Sep 22;167(1):171-186.e15
pubmed: 27641501
N Engl J Med. 1985 Jan 17;312(3):137-41
pubmed: 3880867
Nature. 2012 Feb 15;483(7390):484-8
pubmed: 22343896
Nature. 2014 Jun 12;510(7504):298-302
pubmed: 24805240
Blood. 2007 Mar 1;109(5):1857-61
pubmed: 17105812
Nat Cell Biol. 2018 Jul;20(7):775-781
pubmed: 29941933
Blood. 2015 Sep 10;126(11):1346-56
pubmed: 26186940
Am J Hematol. 2015 Jun;90(6):483-6
pubmed: 25689471
Cancer Cell. 2018 Jul 9;34(1):136-147.e6
pubmed: 29990496
PLoS One. 2009 Dec 07;4(12):e8147
pubmed: 19997560
Cell Metab. 2016 Nov 8;24(5):657-671
pubmed: 27641098
Cancer Res. 2018 May 15;78(10):2669-2679
pubmed: 29490943
J Transl Med. 2017 Jul 19;15(1):158
pubmed: 28724379
Proc Natl Acad Sci U S A. 2017 Oct 24;114(43):11404-11409
pubmed: 29073064
Leukemia. 2002 Apr;16(4):508-19
pubmed: 11960327
Cancer Cell. 2019 Jun 10;35(6):916-931.e9
pubmed: 31185214
Science. 2015 Dec 11;350(6266):1391-6
pubmed: 26541605
Nature. 2007 Apr 12;446(7137):758-64
pubmed: 17344859
Nature. 2009 Dec 10;462(7274):739-44
pubmed: 19935646
Nat Metab. 2019 Aug;1(8):775-789
pubmed: 31579886
Clin Cancer Res. 2004 Oct 1;10(19):6661-8
pubmed: 15475456
Cell Metab. 2012 Jan 4;15(1):110-21
pubmed: 22225880
Science. 2009 Sep 18;325(5947):1555-9
pubmed: 19661383
Blood. 2015 Apr 9;125(15):2386-96
pubmed: 25710880
Science. 2009 May 22;324(5930):1029-33
pubmed: 19460998
FEBS J. 2012 Aug;279(15):2598-609
pubmed: 22672505
Blood. 2012 Feb 23;119(8):1901-3
pubmed: 22215888
J Exp Med. 2016 Jun 27;213(7):1285-306
pubmed: 27325891
Nat Cancer. 2020;1:653-664
pubmed: 33569544
Nat Med. 2017 Oct;23(10):1234-1240
pubmed: 28920959
Cancer Res. 2015 Jun 15;75(12):2530-40
pubmed: 25943877
Science. 2013 May 3;340(6132):626-30
pubmed: 23558169
N Engl J Med. 2004 Aug 5;351(6):533-42
pubmed: 15295046
Sci Transl Med. 2018 Jun 13;10(445):
pubmed: 29899021
Nature. 2018 Jan 25;553(7689):511-514
pubmed: 29342136
Blood. 2017 Aug 10;130(6):722-731
pubmed: 28588020
Nature. 2017 Jun 7;546(7657):234-242
pubmed: 28593971
Blood. 2012 May 24;119(21):4845-50
pubmed: 22496152
Cell Metab. 2019 Sep 3;30(3):556-572.e5
pubmed: 31447321
Cell. 2017 Mar 9;168(6):960-976
pubmed: 28283069
Cancer Cell. 2018 Nov 12;34(5):724-740.e4
pubmed: 30423294
Mol Cell. 2016 Sep 15;63(6):1006-20
pubmed: 27635760
Blood. 2015 Mar 26;125(13):2120-30
pubmed: 25631767
Cell Chem Biol. 2019 May 16;26(5):623-633.e9
pubmed: 30799221
Cancer Cell. 2010 Dec 14;18(6):553-67
pubmed: 21130701
Proc Natl Acad Sci U S A. 2014 Jul 22;111(29):10450-5
pubmed: 24994904
Clin Cancer Res. 2018 May 1;24(9):2060-2073
pubmed: 29437791
PLoS Pathog. 2019 Sep 13;15(9):e1008030
pubmed: 31518366
J Exp Med. 2019 Jul 1;216(7):1509-1524
pubmed: 31142587
Cancer Cell. 2016 Nov 14;30(5):779-791
pubmed: 27746145
Trends Biochem Sci. 2010 Aug;35(8):427-33
pubmed: 20570523
Nat Rev Cancer. 2013 Aug;13(8):572-83
pubmed: 23822983
Nat Cell Biol. 2011 Mar;13(3):310-6
pubmed: 21336310
Cancer Res. 2011 Dec 1;71(23):7291-300
pubmed: 21987722
Blood. 2015 Jun 25;125(26):4060-8
pubmed: 25896651
Cancer Cell. 2019 Oct 14;36(4):369-384.e13
pubmed: 31543463
Cell Metab. 2015 Sep 1;22(3):508-15
pubmed: 26190651
Mol Cancer Res. 2019 Jun;17(6):1365-1377
pubmed: 30862686
Leuk Res. 2018 Apr;67:17-20
pubmed: 29407182
Cell. 2018 Sep 20;175(1):101-116.e25
pubmed: 30220459
Blood. 2007 Apr 1;109(7):2999-3006
pubmed: 17158228
Cancer Metab. 2014 Nov 28;2:17
pubmed: 25671107
Nat Rev Cancer. 2013 Apr;13(4):227-32
pubmed: 23446547
Oncotarget. 2016 Nov 29;7(48):79722-79735
pubmed: 27806325
Blood. 2019 Jan 3;133(1):7-17
pubmed: 30361262
Cancer Res. 2013 May 15;73(10):2998-3006
pubmed: 23585457
Leuk Lymphoma. 2000 Dec;40(1-2):167-78
pubmed: 11426618
Br J Haematol. 2010 Apr;149(1):65-9
pubmed: 20067564
Cell. 2017 Sep 7;170(6):1079-1095.e20
pubmed: 28823558
Blood. 2014 Sep 4;124(10):1645-54
pubmed: 25006128
Nature. 2012 Feb 15;483(7390):479-83
pubmed: 22343889
Leukemia. 2006 Oct;20(10):1731-7
pubmed: 17041637
Proc Natl Acad Sci U S A. 2014 Sep 30;111(39):14015-6
pubmed: 25228774
Proc Natl Acad Sci U S A. 2016 Feb 9;113(6):E782-90
pubmed: 26802124
Blood. 2017 Mar 2;129(9):1124-1133
pubmed: 28115368
Blood. 2015 Sep 10;126(11):1269-70
pubmed: 26359432
N Engl J Med. 2009 Sep 10;361(11):1058-66
pubmed: 19657110
Nat Med. 2017 Mar;23(3):301-313
pubmed: 28191887
Sci Transl Med. 2017 Feb 1;9(375):
pubmed: 28148839
Dev Cell. 2016 Mar 7;36(5):540-9
pubmed: 26954548
Cancer Discov. 2017 May;7(5):478-493
pubmed: 28193778
Ann Oncol. 2015 Sep;26 Suppl 5:v108-15
pubmed: 26314772
Nature. 2016 Sep 22;537(7621):539-543
pubmed: 27626381
Nature. 2017 Nov 2;551(7678):115-118
pubmed: 29045397
Nat Med. 2018 Aug;24(8):1192-1203
pubmed: 29988124
Nat Cell Biol. 2018 Jul;20(7):782-788
pubmed: 29941931
N Engl J Med. 1948 Jun 3;238(23):787-93
pubmed: 18860765
J Biol Chem. 2018 May 18;293(20):7490-7498
pubmed: 29339555
Nat Cell Biol. 2012 Feb 19;14(3):276-86
pubmed: 22344033
Int Rev Cell Mol Biol. 2019;347:1-26
pubmed: 31451211
Nature. 2013 Apr 4;496(7443):101-5
pubmed: 23535601
Blood. 2007 Nov 15;110(10):3507-16
pubmed: 17709603
Cell. 2018 Jan 11;172(1-2):90-105.e23
pubmed: 29249359
J Clin Invest. 2019 Mar 4;129(4):1626-1640
pubmed: 30720463
Results Immunol. 2016 Jan 12;6:8-10
pubmed: 27014565
Nat Rev Immunol. 2019 May;19(5):337-348
pubmed: 30890785
Science. 2013 May 3;340(6132):622-6
pubmed: 23558173
Sci Transl Med. 2017 Jun 28;9(396):
pubmed: 28659443
Nature. 2018 Jan 25;553(7689):515-520
pubmed: 29342133
Clin Cancer Res. 2014 Oct 15;20(20):5255-64
pubmed: 25165100
Nature. 2017 Feb 23;542(7642):479-483
pubmed: 28192788
Cancer Cell. 2012 Oct 16;22(4):547-60
pubmed: 23079663
Diabetes Care. 2008 Dec;31(12):2391-7
pubmed: 19033419
Oncotarget. 2018 Apr 20;9(30):21166-21181
pubmed: 29765528
Blood. 2015 Oct 15;126(16):1925-9
pubmed: 26276667
Cell Rep. 2015 Dec 22;13(11):2353-2361
pubmed: 26686626
Cell Death Dis. 2014 Oct 16;5:e1470
pubmed: 25321477
Haematologica. 2018 Sep;103(9):1472-1483
pubmed: 29880605
N Engl J Med. 2018 Jun 21;378(25):2386-2398
pubmed: 29860938
Cell Metab. 2019 Jun 4;29(6):1243-1257.e10
pubmed: 30827861
Science. 2019 Mar 22;363(6433):1345-1349
pubmed: 30898933
Leukemia. 2017 Oct;31(10):2143-2150
pubmed: 28194038
Cancer Cell. 2017 May 8;31(5):619-620
pubmed: 28486104
Cancer Cell. 2020 Jan 13;37(1):71-84.e7
pubmed: 31935373
PLoS One. 2012;7(8):e44315
pubmed: 22952953
Blood. 2019 Jul 25;134(4):389-394
pubmed: 31101624
J Clin Invest. 2010 Jan;120(1):142-56
pubmed: 20038799
Nat Med. 2018 Jul;24(7):1036-1046
pubmed: 29892070
Cell. 2015 Jul 30;162(3):552-63
pubmed: 26232225
J Leukoc Biol. 2011 Jan;89(1):51-5
pubmed: 20959411
Cell Rep. 2019 Dec 3;29(10):3009-3018.e4
pubmed: 31801069
Cancer Res. 2011 Aug 1;71(15):5204-13
pubmed: 21670080
Mol Cancer Ther. 2015 Oct;14(10):2364-73
pubmed: 26206337
Exp Hematol. 2019 Oct;78:46-55.e3
pubmed: 31560931
Proc Natl Acad Sci U S A. 1997 Jun 24;94(13):6658-63
pubmed: 9192621
Cell. 2012 Apr 27;149(3):656-70
pubmed: 22541435
Cell Metab. 2020 Apr 7;31(4):852-861.e6
pubmed: 32268116
Sci Rep. 2015 Jan 28;5:8068
pubmed: 25626693
Leukemia. 2017 Nov;31(11):2326-2335
pubmed: 28280275
Nat Rev Cancer. 2016 Nov;16(11):694-707
pubmed: 27634449
Nature. 2009 Apr 9;458(7239):762-5
pubmed: 19219026
Leukemia. 2015 May;29(5):1163-76
pubmed: 25394713
Nature. 2012 Feb 15;483(7390):474-8
pubmed: 22343901
Sci Transl Med. 2019 May 8;11(491):
pubmed: 31068440
Nat Med. 2013 Mar;19(3):368-71
pubmed: 23377281
Trends Cancer. 2018 Feb;4(2):151-165
pubmed: 29458964
Nat Med. 2015 Oct;21(10):1182-9
pubmed: 26390244
PLoS One. 2013 Dec 13;8(12):e82859
pubmed: 24349380
Science. 1956 Feb 24;123(3191):309-14
pubmed: 13298683
Cell. 2016 Feb 11;164(4):681-94
pubmed: 26853473
Leukemia. 2006 Jul;20(7):1303-6
pubmed: 16598302
Cancer Cell. 2018 Oct 8;34(4):659-673.e6
pubmed: 30270124

Auteurs

Maximilian Stahl (M)

Department of Medicine and Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.

Zachary D Epstein-Peterson (ZD)

Department of Medicine and Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.

Andrew M Intlekofer (AM)

Department of Medicine and Human Oncology & Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH